U.S., Feb. 9 -- ClinicalTrials.gov registry received information related to the study (NCT06251895) titled 'Association of Systemic Immune-inflammation Index and Severity of Diabetic Ketoacidosis in Type 1 Diabetes Mellitus' on Jan. 23.
Brief Summary: Diabetic ketoacidosis (DKA) is the most serious metabolic complication of type 1 diabetes mellitus (T1DM). Insulin deficiency and inflammation play a role in the pathogenesis of DKA. The investigators aim to assess the systemic immune-inflammation index (SII) as a marker of severity among T1DM patients with DKA and without infection.
Study Type: Observational
Condition: Diabetic Ketoacidosis
Intervention: Other: DKA protocol
IV fluids and IV insulin as per guidelines. reference 1-2
Recru...